EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPS0pNQnFBWENtcFppVm1lNnZ1RnVRV3pYT2luc2RnMk9QYVFrb1g5VkVQNXlDbXdRMnR2Yk54Ym9mX0xiSnJPbDI1T29GNTVNeGFuUFFzZDZ4OXQxcGo2QlVkRU1velpHUTQ4WGdrcGdaTHlmMkUxVWlQMVBkWFNmVFdBMzBzaGYwZlQ0MFF5ak1qWC1IOGxtN2RQdGhhVkFBWFJfbDZZMEFIbF9FRVVjSG83NWdsTzFmVF9wMGtySTFCQQ?oc=5" target="_blank">EyePoint's drug for age-related eye disease fails late-stage trial, shares tank</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMModerna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
August 19, 2026 at 12:17 PMVIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
August 19, 2026 at 02:45 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMCerebras shares plummet 16% after results fail to impress investors - Reuters
Cerebras shares plummet 16% after results fail to impress investors Reuters
August 12, 2026 at 11:45 PMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PM